loading
前日終値:
$33.12
開ける:
$32.7
24時間の取引高:
42,865
Relative Volume:
0.68
時価総額:
$225.69M
収益:
-
当期純損益:
$-4.98M
株価収益率:
-24.32
EPS:
-1.3177
ネットキャッシュフロー:
$-3.85M
1週間 パフォーマンス:
-12.22%
1か月 パフォーマンス:
-0.59%
6か月 パフォーマンス:
+2,662%
1年 パフォーマンス:
+2,365%
1日の値動き範囲:
Value
$30.00
$33.65
1週間の範囲:
Value
$30.00
$38.33
52週間の値動き範囲:
Value
$0.93
$79.02

Bright Minds Biosciences Inc Stock (DRUG) Company Profile

Name
名前
Bright Minds Biosciences Inc
Name
セクター
Healthcare (1162)
Name
電話
-
Name
住所
-
Name
職員
0
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
DRUG's Discussions on Twitter

DRUG を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
DRUG
Bright Minds Biosciences Inc
32.04 225.69M 0 -4.98M -3.85M -1.3177
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 33.86B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 30.51B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 25.69B 3.81B -644.79M -669.77M -6.24

Bright Minds Biosciences Inc Stock (DRUG) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-01-23 開始されました Piper Sandler Overweight
2025-01-10 開始されました Cantor Fitzgerald Overweight
2025-01-10 開始されました H.C. Wainwright Buy
2024-11-26 開始されました Robert W. Baird Outperform

Bright Minds Biosciences Inc (DRUG) 最新ニュース

pulisher
Apr 03, 2025

Reviewing Allarity Therapeutics (NASDAQ:ALLR) & Bright Minds Biosciences (NASDAQ:DRUG) - Defense World

Apr 03, 2025
pulisher
Apr 01, 2025

Discover the Top 5 Small-Cap Biotech Stocks in 2025 - Investing News Network

Apr 01, 2025
pulisher
Mar 21, 2025

Bright Minds Biosciences Inc. (NASDAQ:DRUG) Sees Significant Decrease in Short Interest - Defense World

Mar 21, 2025
pulisher
Mar 18, 2025

DRUG FY2025 EPS Estimate Decreased by Cantor Fitzgerald - The AM Reporter

Mar 18, 2025
pulisher
Mar 18, 2025

Cantor Fitzgerald Has Weak Forecast for DRUG FY2025 Earnings - Defense World

Mar 18, 2025
pulisher
Mar 15, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Trading Down 0.8% – Here’s Why - Defense World

Mar 15, 2025
pulisher
Mar 09, 2025

Bright Minds Biosciences Independent Director Nils Bottler Sells 100% Of Holding - simplywall.st

Mar 09, 2025
pulisher
Mar 04, 2025

Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Leaders in Epilepsy Research - GlobeNewswire

Mar 04, 2025
pulisher
Mar 04, 2025

Bright Minds Biosciences Strengthens Epilepsy Focus with New Advisory Board Members - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Can These 5 Epilepsy Experts Accelerate Bright Minds' Breakthrough Drug Development? - StockTitan

Mar 04, 2025
pulisher
Feb 24, 2025

Bright Minds Biosciences to Participate at Three Healthcare Conferences in March - The Manila Times

Feb 24, 2025
pulisher
Feb 24, 2025

Can This CNS Drug Developer's Triple Conference Tour Spark Investor Interest? - StockTitan

Feb 24, 2025
pulisher
Feb 23, 2025

How the (DRUG) price action is used to our Advantage - news.stocktradersdaily.com

Feb 23, 2025
pulisher
Feb 22, 2025

HC Wainwright Issues Negative Estimate for DRUG Earnings - Defense World

Feb 22, 2025
pulisher
Feb 21, 2025

H.C. Wainwright maintains $85 target on Bright Minds stock By Investing.com - Investing.com Nigeria

Feb 21, 2025
pulisher
Feb 20, 2025

H.C. Wainwright maintains $85 target on Bright Minds stock - Investing.com India

Feb 20, 2025
pulisher
Feb 20, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Given “Buy” Rating at HC Wainwright - Defense World

Feb 20, 2025
pulisher
Feb 19, 2025

Bright Minds Biosciences’ BMB-101: A Promising Contender in Serotonergic Epilepsy Treatment with Strong Market Potential - TipRanks

Feb 19, 2025
pulisher
Feb 14, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Announces Earnings Results, Beats Estimates By $0.24 EPS - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

Bright Minds Biosciences Dramatic Surge Highlights the High-Stakes Nature of Biotech Investments - HPBL

Feb 14, 2025
pulisher
Feb 14, 2025

BriaCell Therapeutics: A Biotech Stock on the Brink of a Turnaround? - HPBL

Feb 14, 2025
pulisher
Feb 14, 2025

Biotechs on the Brink: 2 Stocks With Huge Potential - Benzinga

Feb 14, 2025
pulisher
Feb 14, 2025

Bright Minds Biosciences Shows Financial Improvement in Latest Report - TipRanks

Feb 14, 2025
pulisher
Feb 12, 2025

When (DRUG) Moves Investors should Listen - Stock Traders Daily

Feb 12, 2025
pulisher
Feb 05, 2025

SEC Form F-3 filed by Bright Minds Biosciences Inc. - Quantisnow

Feb 05, 2025
pulisher
Feb 04, 2025

More Money In The Bank For Bright Minds Biosciences Insiders Who Divested CA$16m - Simply Wall St

Feb 04, 2025
pulisher
Feb 04, 2025

How To Buy Bright Minds Biosciences Inc. Stock Online in February 2025 - Traders Union

Feb 04, 2025
pulisher
Jan 31, 2025

Long Term Trading Analysis for (DRUG) - Stock Traders Daily

Jan 31, 2025
pulisher
Jan 26, 2025

Bright Minds Biosciences: Looking To Change Scope Of Epilepsy Disorder Treatments With BMB-101 - Seeking Alpha

Jan 26, 2025
pulisher
Jan 26, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Research Coverage Started at Piper Sandler - Defense World

Jan 26, 2025
pulisher
Jan 24, 2025

Piper Sandler sets $93 target for Bright Minds Biosciences stock - MSN

Jan 24, 2025
pulisher
Jan 24, 2025

Piper Sandler Initiates Coverage of Bright Minds Biosciences (DRUG) with Overweight Recommendation - MSN

Jan 24, 2025
pulisher
Jan 24, 2025

Piper Sandler sets $93 target for Bright Minds Biosciences stock By Investing.com - Investing.com South Africa

Jan 24, 2025
pulisher
Jan 24, 2025

Cantor Fitzgerald Predicts DRUG FY2025 Earnings - Defense World

Jan 24, 2025
pulisher
Jan 23, 2025

Cantor Fitzgerald Comments on DRUG FY2025 Earnings - MarketBeat

Jan 23, 2025
pulisher
Jan 23, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Now Covered by Analysts at Piper Sandler - MarketBeat

Jan 23, 2025
pulisher
Jan 23, 2025

This Prudential Financial Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday - Benzinga

Jan 23, 2025
pulisher
Jan 22, 2025

5-HT2 Agonist Clinical Trial Pipeline Appears Robust With - GlobeNewswire

Jan 22, 2025
pulisher
Jan 21, 2025

Learn to Evaluate (DRUG) using the Charts - Stock Traders Daily

Jan 21, 2025
pulisher
Jan 16, 2025

Bright Minds Biosciences Appoints New Chief Medical Officer to Advance CNS Therapeutics - MSN

Jan 16, 2025
pulisher
Jan 14, 2025

Top 4 Canadian Biotech Stocks (Updated January 2025) - Investing News Network

Jan 14, 2025
pulisher
Jan 14, 2025

Head-To-Head Analysis: Bright Minds Biosciences (NASDAQ:DRUG) versus Enlivex Therapeutics (NASDAQ:ENLV) - Defense World

Jan 14, 2025
pulisher
Jan 12, 2025

Cantor Fitzgerald Begins Coverage on Bright Minds Biosciences (NASDAQ:DRUG) - Defense World

Jan 12, 2025
pulisher
Jan 12, 2025

HC Wainwright Begins Coverage on Bright Minds Biosciences (NASDAQ:DRUG) - Defense World

Jan 12, 2025
pulisher
Jan 10, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Coverage Initiated by Analysts at Cantor Fitzgerald - MarketBeat

Jan 10, 2025
pulisher
Jan 10, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Earns Buy Rating from Analysts at HC Wainwright - MarketBeat

Jan 10, 2025
pulisher
Jan 10, 2025

Cantor Fitzgerald Initiates Coverage of Bright Minds Biosciences (DRUG) with Overweight Recommendation - MSN

Jan 10, 2025
pulisher
Jan 08, 2025

Top 5 Small-cap Biotech Stocks (Updated January 2025) - Nasdaq

Jan 08, 2025
pulisher
Jan 07, 2025

Bright Minds Biosciences Appoints Pharmaceutical Leader, Stephen Collins, M.D., Ph.D., as Chief Medical Officer - The Manila Times

Jan 07, 2025

Bright Minds Biosciences Inc (DRUG) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Bright Minds Biosciences Inc (DRUG) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Cormorant Asset Management, LP
10% Owner
Oct 15 '24
Buy
5.53
372,591
2,061,574
825,000
Cormorant Asset Management, LP
10% Owner
Oct 16 '24
Buy
23.46
50,000
1,172,813
875,000
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
大文字化:     |  ボリューム (24 時間):